Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Edwards Lifesciences Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
- Liabilities Trend
- The proportion of total liabilities relative to total liabilities and stockholders' equity shows a consistent decline over the analyzed period, decreasing from 48.10% in 2017 to 31.36% in 2021. Both current liabilities and long-term liabilities decreased contributing to this overall trend. Current liabilities fell from 24.63% to 12.14%, while long-term liabilities decreased from 23.47% to 19.22%. This reduction indicates a gradual deleveraging or a shift in capital structure.
- Current Liabilities Composition
- Among current liabilities, accounts payable increased slightly from 2.05% in 2017 peaking at 2.78% in 2019 before declining to 2.41% in 2021. Employee compensation and withholdings showed variability, decreasing notably in 2020 (3.27%) before rising again to 3.76% in 2021. Accrued rebates fell after a peak in 2018 (1.50%) to 0.91% by 2021. Other components such as accrued marketing expenses and accrued professional services remained relatively stable at low percentages. The presence of short-term debt was only noted in 2017 (10.50%), after which it is absent, indicating potential repayment or reclassification.
- Long-term Liabilities Composition
- Long-term debt declined from 7.70% to 7.01%, with fluctuations in contingent consideration liabilities, which significantly dropped from 3.38% in 2017 to 0.73% in 2021. Taxes payable and uncertain tax positions showed a steady decrease and subsequent stabilization, respectively. The addition of operating lease liabilities post-2019, both current and long-term portions, suggests recognition of lease obligations under updated accounting standards, though these remain a relatively small component.
- Stockholders' Equity Evolution
- Stockholders’ equity increased steadily over the period, rising from 51.90% to 68.64%. This increase is primarily driven by substantial growth in retained earnings, which climbed from 34.45% in 2017 to 71.37% in 2021, indicating accumulated profitability. Common stock as a proportion of total financing experienced fluctuations, notably increasing sharply in 2020. Additional paid-in capital remained relatively stable around 20-26%. Treasury stock at cost expanded as a negative component, increasing the magnitude of shares repurchased and held by the company, moving from -4.43% to -28.43%, reflecting significant buyback activity. Accumulated other comprehensive loss decreased in absolute negative percentage terms, indicating a slight reduction in unrealized losses or adjustments.
- Other Observations
- There was a notable spike in legal and insurance accruals in 2018 (3.69%) followed by a return to lower levels, which could suggest a one-time legal event or settlement during that year. Litigation settlement accruals appeared only in 2020 and 2021 with values of 3.22% and 2.25%, respectively, likely related to legal contingencies. Various minor accrued liabilities such as realignment reserves and relocation costs showed modest upward trends, reflecting ongoing operational adjustments.
- Overall Financial Position
- The data suggests a strengthening financial position with increased equity financing and reduction of liabilities relative to total financing. The significant increase in retained earnings signals improving profitability or earnings retention. The reduction in liabilities alongside growing equity and active treasury stock indicates enhanced capitalization and shareholder value return efforts. The recorded lease liabilities from 2019 onwards indicate compliance with updated accounting standards affecting reported liabilities.